Omidenepag Isopropyl Chemical Properties,Usage,Production
Uses
Omidenepag Isopropyl is a derivative of Omidenepag (O635205) which is a novel selective, non-prostanoid EP2 receptor agonist for the treatment of Glaucoma:
Omidenepag isopropyl (OMDI), administered as a 0.002% ophthalmic solution, was approved in Japan in 2018 for treating glaucoma and ocular hypertension.
